Nigeria is in talks with the World Bank’s private lending arm and other lenders to raise about N12.3 billion ($30m) to help finance a vaccine plant, three decades after the nation’s only production facility was shut.
Biovaccines Nigeria Limited, which is 49 percent owned by the Nigerian gover
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
